
Quantitative Assessment of En‑face OCT‑Derived Minimum Intensity Fluid Changes Following Ranibizumab Biosimilar Therapy ...
Introduction Age-related macular degeneration (AMD) is a leading cause of irreversible visual loss in older adults globally.1 With aging populations, the burden of AMD is increasing rapidly. Nearly 200 million people were affected in 2020, projected to …